The FDA announced its intention to start regulating tests developed in laborator...
In a highly unusual move, Unitaid has publicly criticized Johnson & Johnson over...
A handful of the largest purveyors of generic medicines have made only halting p...
Prescription medicines purchased in the U.S. under a controversial government di...
The WHO has recommended dropping a component of many flu vaccines because the vi...
The deadline for drugmakers to sign agreements to negotiate with Medicare on pri...
In 2021, women paid about 20% more for out-of-pocket medical expenses than men —...
Rapid, complex, and technically sound data analysis is insufficient — and someti...
The shrinking of Taysha Gene Therapies has left many families, who funded the ea...
The CEO of Mass General Brigham discussed the system’s split with Dana-Farber Ca...
At the industry crossroads of healthcare and pharmaceuticals at the Life Science...
Amicus Therapeutics has received approval from the US FDA for the two-component ...
HitGen and the Structural Genomics Consortium entered a collaboration to discove...
Deka Biosciences has secured funding of $20m in a Series B2 financing round to a...
The FDA has set 31 March 2024 as the PDUFA action date for reviewing odronextama...
The stem cell startup aims to bolster immune systems of patients born without a ...
